canrenoic acid

Preferred Label : canrenoic acid;

MeSH definition : A synthetic pregnadiene derivative with anti-aldosterone activity.;

MeSH synonym : acid, canrenoic; 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic acid; 17 hydroxy 3 oxo 17alpha pregna 4,6 diene 21 carboxylic acid; acid, 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic;

CISMeF synonym : searle brand of canrenoate potassium; pharmacia brand of canrenoate potassium; Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, monopotassium salt, (17alpha)-; ratiopharm brand of canrenoate potassium; pfizer brand of canrenoate potassium; boehringer mannheim brand of canrenoate potassium;

DeCS synonym : Kalium Can. Ratiopharm;

MeSH hyponym : spiroctan; Kalium-Can.-ratiopharm; canrenoate potassium; soludactone; SC-14266; Kalium Can. Ratiopharm; Soldactone; Potassium Canrenoate; Canrenoate, Potassium; SC 14266; SC14266;

MeSH Related Number : 2181-04-6 (Canrenoate potassium); 4138-96-9 (Canrenoic acid); canrenoate potassium; M671F9NLEA;

Registry Number MeSH : 2181-04-6;

Related CAS MeSH : M671F9NLEA (Canrenoate potassium);

Wikipedia link : https://en.wikipedia.org/wiki/Canrenoate potassium;

Codes EINECS : 218-554-9;

Is substance : O;

UNII : 87UG89VA9K;

InChIKey : PBKZPPIHUVSDNM-WNHSNXHDSA-N;

Details

Origin ID

D002191;

UMLS CUI

C0282085;

ATC code(s)
- potassium canrenoate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Potassium canrenoate [ICHI extension code]
Pharmacological action(s)
- diuretics [MeSH Descriptor]
- mineralocorticoid receptor antagonists [MeSH Descriptor]
Record concept(s)
- Kalium-Can.-ratiopharm [MeSH concept]
- SC-14266 [MeSH concept]
- canrenoate potassium [MeSH concept]
- canrenoic acid [MeSH concept]
- soludactone [MeSH concept]
- spiroctan [MeSH concept]
Related MeSH Supplementary Concept(s)
- althiazide, canrenoate potassium, rescinnamine drug combination [MeSH Supplementary Concept]
SNOMED CT : is a
- mineralocorticoid receptor antagonists [MeSH Descriptor]
See also inter- (CISMeF)
- Canrenoate Potassium [NCIt concept]
- Potassium canrenoate [ICD-11 Extension code]
- Potassium canrenoate (substance) [SNOMED CT concept]
- potassium canrenoate [Substance BNPC]
- potassium canrenoate [ATC Code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Canrenoic Acid [NCIt concept]
- Canrenoic acid [ICD-11 Extension code]
- canrenoic acid [Substance BNPC]
Validated automatic mappings to BTNT
- Potassium canrenoate [SMS substance]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients